Enitociclib (VIP152/formerly BAY1251152) Is a Selective and Active CDK9 Inhibitor : Preliminary Safety and Early Signs of Efficacy in Patients with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Autor: | Shadman, Mazyar, Mato, Anthony R., Batlevi, Connie Lee, Flinn, Ian W., Gutierrez, Martin *, Uemura, Marc *, Stevens, Don A., Morillo, Daniel *, Byrd, John C., Frigault, Melanie M., Clemens, George *, Huang, Xin *, Izumi, Raquel, Wong, Harvey *, Breed, Renee *, Garban, Hermes *, Johnson, Amy J., Stelte-Ludwig, Beatrix *, Mithal, Arushi *, Birkett, Joseph *, Hamdy, Ahmed, Rogers, Kerry A. |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:9454-9456 |
Databáze: | ScienceDirect |
Externí odkaz: |